Parenteral short-term corticosteroid therapy in moderate to severe dermatoses. A comparative multiclinic study

Area of Science:

• Dermatology
• Pharmacology

Background:

• Contact dermatitis and atopic dermatitis are common inflammatory skin conditions.
• Effective treatment options are crucial for managing symptoms such as pruritus and inflammation.

Purpose of the Study:

• To compare the efficacy of betamethasone sodium phosphate ester versus dexamethasone sodium phosphate.
• To evaluate treatment outcomes for patients with Rhus dermatitis, other contact dermatitis, and atopic dermatitis.

Main Methods:

• A double-blind study involving 124 patients with various dermatitis types.
• Intramuscular injections of betamethasone sodium phosphate ester or dexamethasone sodium phosphate were administered.
• Standardized protocol followed by six investigators.

Main Results:

• Both drugs demonstrated dramatic and comparable responses in reducing dermatitis signs and symptoms.
• Significant symptom reduction, including pruritus, burning, and inflammation, observed within 24 hours.
• Betamethasone showed more frequent significant beneficial differences compared to dexamethasone.

Conclusions:

• Betamethasone sodium phosphate ester and dexamethasone sodium phosphate are effective treatments for dermatitis.
• No treatment failures or side effects were reported in this short-term trial.
• Betamethasone may offer slightly superior benefits for certain dermatitis symptoms.